These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 32460144)

  • 21. Susceptibility to SARS, MERS, and COVID-19 from animal health perspective.
    Gautam A; Kaphle K; Shrestha B; Phuyal S
    Open Vet J; 2020 Aug; 10(2):164-177. PubMed ID: 32821661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of COVID-19 Outbreak on Immune Therapies in Multiple Sclerosis Patients-Lessons Learned From SARS and MERS.
    Möhn N; Pul R; Kleinschnitz C; Prüss H; Witte T; Stangel M; Skripuletz T
    Front Immunol; 2020; 11():1059. PubMed ID: 32477373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses.
    Abdelrahman Z; Li M; Wang X
    Front Immunol; 2020; 11():552909. PubMed ID: 33013925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Severe COVID-19: what have we learned with the immunopathogenesis?
    Bordallo B; Bellas M; Cortez AF; Vieira M; Pinheiro M
    Adv Rheumatol; 2020 Sep; 60(1):50. PubMed ID: 32962761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype and kinetics of SARS-CoV-2-specific T cells in COVID-19 patients with acute respiratory distress syndrome.
    Weiskopf D; Schmitz KS; Raadsen MP; Grifoni A; Okba NMA; Endeman H; van den Akker JPC; Molenkamp R; Koopmans MPG; van Gorp ECM; Haagmans BL; de Swart RL; Sette A; de Vries RD
    Sci Immunol; 2020 Jun; 5(48):. PubMed ID: 32591408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The bio-mission of interleukin-6 in the pathogenesis of COVID-19: A brief look at potential therapeutic tactics.
    Abbasifard M; Khorramdelazad H
    Life Sci; 2020 Sep; 257():118097. PubMed ID: 32679148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oxidative Stress as Key Player in Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) Infection.
    Delgado-Roche L; Mesta F
    Arch Med Res; 2020 Jul; 51(5):384-387. PubMed ID: 32402576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopathogenesis of Coronavirus-Induced Acute Respiratory Distress Syndrome (ARDS): Potential Infection-Associated Hemophagocytic Lymphohistiocytosis.
    Quan C; Li C; Ma H; Li Y; Zhang H
    Clin Microbiol Rev; 2020 Oct; 34(1):. PubMed ID: 33055229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An updated insight into the molecular pathogenesis, secondary complications and potential therapeutics of COVID-19 pandemic.
    Jamwal S; Gautam A; Elsworth J; Kumar M; Chawla R; Kumar P
    Life Sci; 2020 Sep; 257():118105. PubMed ID: 32687917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls.
    Le Bert N; Tan AT; Kunasegaran K; Tham CYL; Hafezi M; Chia A; Chng MHY; Lin M; Tan N; Linster M; Chia WN; Chen MI; Wang LF; Ooi EE; Kalimuddin S; Tambyah PA; Low JG; Tan YJ; Bertoletti A
    Nature; 2020 Aug; 584(7821):457-462. PubMed ID: 32668444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural Killer Cell Dysfunction and Its Role in COVID-19.
    van Eeden C; Khan L; Osman MS; Cohen Tervaert JW
    Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32883007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Overview of lethal human coronaviruses.
    Chen B; Tian EK; He B; Tian L; Han R; Wang S; Xiang Q; Zhang S; El Arnaout T; Cheng W
    Signal Transduct Target Ther; 2020 Jun; 5(1):89. PubMed ID: 32533062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The dynamics of humoral immune responses following SARS-CoV-2 infection and the potential for reinfection.
    Kellam P; Barclay W
    J Gen Virol; 2020 Aug; 101(8):791-797. PubMed ID: 32430094
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Covid-19: Perspectives on Innate Immune Evasion.
    Taefehshokr N; Taefehshokr S; Hemmat N; Heit B
    Front Immunol; 2020; 11():580641. PubMed ID: 33101306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
    Liu YJ; Yang YL; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):339-344. PubMed ID: 32294817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cytokine super cyclone in COVID-19 patients with risk factors: the therapeutic potential of BCG immunization.
    Johnson BS; Laloraya M
    Cytokine Growth Factor Rev; 2020 Aug; 54():32-42. PubMed ID: 32747157
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis and COVID-19: Lessons from the Past Viral Outbreaks and Possible Future Outcomes.
    Crisan-Dabija R; Grigorescu C; Pavel CA; Artene B; Popa IV; Cernomaz A; Burlacu A
    Can Respir J; 2020; 2020():1401053. PubMed ID: 32934758
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cyclosporine therapy during the COVID-19 pandemic.
    Rudnicka L; Glowacka P; Goldust M; Sikora M; Sar-Pomian M; Rakowska A; Samochocki Z; Olszewska M
    J Am Acad Dermatol; 2020 Aug; 83(2):e151-e152. PubMed ID: 32376422
    [No Abstract]   [Full Text] [Related]  

  • 39. Differential immune activation profile of SARS-CoV-2 and SARS-CoV infection in human lung and intestinal cells: Implications for treatment with IFN-β and IFN inducer.
    Shuai H; Chu H; Hou Y; Yang D; Wang Y; Hu B; Huang X; Zhang X; Chai Y; Cai JP; Chan JF; Yuen KY
    J Infect; 2020 Oct; 81(4):e1-e10. PubMed ID: 32707230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
    Sarzi-Puttini P; Giorgi V; Sirotti S; Marotto D; Ardizzone S; Rizzardini G; Antinori S; Galli M
    Clin Exp Rheumatol; 2020; 38(2):337-342. PubMed ID: 32202240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.